60 active trials 30 recruiting 22 Phase 3 10 disease areas 13 changes in 30 days
| Phase 1 | 16 | |
| Phase 1/2 | 6 | |
| Phase 2 | 13 | |
| Phase 3 | 22 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT06585774 | A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic… | Chronic Graft-versus-host-disease | Recruiting | 2026-08-06 |
| NCT06855498 | Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib | Hidradenitis Suppurativa (HS) | Recruiting | 2026-08-06 |
| NCT07214779 | Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants… | Ovarian Cancer | Recruiting | 2026-08-06 |
| NCT07284849 | A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and… | CRC (Colorectal Cancer) | Recruiting | 2026-08-06 |
| NCT07522073 | A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS… | Solid Tumors | Recruiting | 2026-08-06 |
| NCT07623200 | A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With… | Essential Thrombocythemia | Recruiting | 2026-08-06 |
| NCT06548360 | A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric… | NonSegmental Vitiligo | Recruiting | 2026-07-23 |
| NCT06804811 | A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12… | NonSegmental Vitiligo | Recruiting | 2026-07-22 |
| NCT06615050 | A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant… | Graft-versus-host Disease (GVHD) | Recruiting | 2026-05-20 |
| NCT06113445 | A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental… | NonSegmental Vitiligo | Active, Not Recruiting | 2026-08-25 |
| NCT06212999 | A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants… | Hidradenitis Suppurativa (HS) | Active, Not Recruiting | 2026-08-25 |
| NCT06821542 | A Study to Evaluate Axatilimab Versus Best Available Therapy in Participants With Chronic… | Chronic Graft-versus-host-disease | Active, Not Recruiting | 2026-08-25 |
| NCT06832618 | A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and… | Atopic Dermatitis | Active, Not Recruiting | 2026-08-19 |
| NCT06959225 | Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With… | Hidradenitis Suppurativa | Active, Not Recruiting | 2026-07-28 |
| NCT06958211 | Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With… | Hidradenitis Suppurativa | Active, Not Recruiting | 2026-07-08 |
| NCT06516952 | A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With… | Prurigo Nodularis | Active, Not Recruiting | 2026-05-28 |
| NCT05429268 | Study to Evaluate the Safety and Efficacy of Tafasitamab Plus Lenalidomide in… | Large B-Cell Lymphoma | Active, Not Recruiting | 2026-05-05 |
| NCT06516965 | A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With… | Prurigo Nodularis | Active, Not Recruiting | 2026-04-14 |
| NCT04824092 | Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate… | Diffuse Large B-cell Lymphoma | Active, Not Recruiting | 2026-04-01 |
| NCT06113471 | A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental… | NonSegmental Vitiligo | Active, Not Recruiting | 2026-03-31 |
| NCT06263478 | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Axatilimab Monotherapy… | Chronic Graft-versus-host-disease | Active, Not Recruiting | 2026-01-07 |
| NCT04680052 | A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and… | Follicular Lymphoma | Active, Not Recruiting | 2025-12-22 |
| Phase 2 | ||||
| NCT07124078 | A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants… | Chronic Graft-versus-host-disease | Recruiting | 2026-08-25 |
| NCT07023627 | A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin… | Ovarian Cancer | Recruiting | 2026-08-06 |
| NCT07104565 | Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With… | Immune Thrombocytopenia | Recruiting | 2026-08-06 |
Myelofibrosis (7) · Hidradenitis Suppurativa (6) · DLBCL (3) · Atopic Dermatitis (3) · Colorectal Cancer (2) · Ovarian Cancer (2) · Lung Cancer (1) · Breast Cancer (1) · Pancreatic Cancer (1) · Leukemia (1)